Clinical Impact of Remdesivir in Moderate COVID-19 Unclear
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
p16INK4a Expression Increased in Young Cancer Survivors
Signs of age acceleration at molecular level also seen in frail survivors, in children after cancer therapy
RAAS Inhibitors May Benefit HTN Patients With COVID-19
Risk for death, death/critical outcomes lower with use of RAAS inhibitors for hypertension
Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer
Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers
Antihypertensive Agents Not Tied to Higher Risk for Depression
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
Black-White Disparity in Lung Cancer Incidence Eliminated
Historical trend of increased incidence in Blacks versus Whites disappeared in men, reversed in women
For Black Children With Autism, Diagnosis Occurs at About Age 5
On average, diagnosis occurs 3.5 years after parents' first concerns about the child's development
School-Located Influenza Vaccine Intervention Beneficial
SLIV intervention linked to drop in incidence of influenza hospitalization in school-aged children, adults
Feeling Dizzy Upon Standing May Point to Later Dementia
Dementia link seen only in people who have a drop in their systolic blood pressure
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
